Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
Latest Information Update: 23 Dec 2022
At a glance
- Drugs Naltrexone (Primary) ; Buprenorphine/naloxone
- Indications Heroin-related disorders; Opioid-related disorders
- Focus Therapeutic Use
Most Recent Events
- 04 Feb 2022 Status changed from recruiting to discontinued. Reason the study was stopped: continuing study was no longer feasible.
- 31 Jan 2021 Planned End Date changed from 1 Apr 2021 to 1 Apr 2022.
- 31 Jan 2021 Planned primary completion date changed from 31 Dec 2020 to 31 Dec 2021.